OPRXHealthcareMicro-Cap

OptimizeRx Corp Insider Trading Activity

Every SEC Form 4 insider transaction reported for OptimizeRx Corp (OPRX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are OPRX insiders buying or selling?

OptimizeRx Corp insiders reported 25 open-market buys ($4.1M) and 59 sells ($37.8M) across 84 Form 4 filings — a net selling position of $33.8M.

Source: SEC EDGAR Form 4

Key Statistics (as of Dec 22, 2025)

Total Form 4 filings
84
SEC EDGAR
Insider filers
13
Insider buys (25)
$4.1M
Insider sells (59)
$37.8M

Insider sentiment

Net selling

Net insider flow of $33.8M in net selling.

Recent OPRX insider transactions

DateInsiderRoleTypeSharesPriceValue
Dec 22, 2025Edward StelmakhChief Finance & Strat OfficerSale1.4K$13.51$18.8K
Oct 7, 2025Stephen L SilvestroChief Executive OfficerSale1.6K$18.75$30.4K
Sep 11, 2025Patrick D SpanglerDirectorSale11.1K$17.49$194.5K
Mar 19, 2025James Paul LangDirectorPurchase321.4K$7.60$2.4M
Dec 16, 2024William J FebboCEOPurchase20.0K$5.01$100.2K
Jan 11, 2024Marion Odence-FordGeneral Counsel and CCOSale4.0K$15.19$60.8K
Aug 23, 2022James Paul LangDirectorPurchase6.0K$16.45$98.7K
Aug 23, 2022William J FebboCEOPurchase16.1K$15.59$251.0K
Aug 17, 2022Stephen L SilvestroCCOPurchase3.2K$15.66$50.1K
Aug 17, 2022Ellen O'Connor VosDirectorPurchase500$15.91$8.0K
Aug 17, 2022Edward StelmakhCFO/COOPurchase3.0K$15.43$46.3K
Feb 23, 2022William J FebboCHIEF EXECUTIVE OFFICERSale16.7K$43.73$728.8K
Jan 20, 2022William J FebboCHIEF EXECUTIVE OFFICERSale16.7K$47.27$787.8K
Dec 21, 2021Stephen L SilvestroCHIEF COMMERCIAL OFFICERSale13.2K$54.87$726.5K
Dec 17, 2021William J FebboCHIEF EXECUTIVE OFFICERSale16.7K$54.55$909.1K
Dec 3, 2021Miriam J ParamorePRESIDENT AND CSOSale3.6K$61.48$218.7K
Nov 19, 2021Stephen L SilvestroCHIEF COMMERCIAL OFFICERSale13.2K$73.98$979.6K
Nov 17, 2021William J FebboCHIEF EXECUTIVE OFFICERSale16.7K$82.18$1.4M
Nov 15, 2021Patrick D SpanglerDirectorSale6.3K$84.38$527.5K
Nov 3, 2021Miriam J ParamorePRES. & CHIEF STRATEGY OFFICERSale15.0K$95.45$1.4M
Oct 19, 2021Stephen L SilvestroCHIEF COMMERCIAL OFFICERSale13.2K$85.38$1.1M
Oct 19, 2021William J FebboCHIEF EXECUTIVE OFFICERSale16.7K$84.20$1.4M
Oct 5, 2021Miriam J ParamorePRESIDENT AND CSOSale15.0K$84.67$1.3M
Oct 5, 2021Douglas P BakerCHIEF FINANCIAL OFFICERSale14.0K$82.88$1.2M
Sep 29, 2021Douglas P BakerCHIEF FINANCIAL OFFICERSale2.0K$74.66$149.3K

Showing the 25 most recent of 84 Form 4 filings for OptimizeRx Corp.

Most active OPRX insiders

  • Douglas P Baker26 filings
  • William J Febbo14 filings
  • Miriam J Paramore11 filings
  • Stephen L Silvestro10 filings
  • Ellen O'Connor Vos6 filings

Ask anything about OPRX insider activity

Use Trabud's AI agent to query OptimizeRx Corp's Form 4 history in plain English — "Show me OPRX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

OPRX insider trading FAQ

Are OptimizeRx Corp insiders buying or selling?

Across 84 SEC Form 4 filings, OptimizeRx Corp (OPRX) insiders reported 25 open-market purchases totaling $4.1M and 59 sales totaling $37.8M. That is a net selling position of $33.8M.

How many insiders trade OPRX stock?

13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for OptimizeRx Corp. The most recent filing was accepted on Dec 22, 2025.

Where does Trabud get OPRX insider trading data?

All OPRX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content